3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
9
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Prostatic Neoplasms
7
Uterine Cervical Neoplasms
5
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Retinoblastoma
1
Radiation Injuries
1
Ovarian Neoplasms
1
Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Genital Neoplasms, Female
1
Endometrial Neoplasms
1
Breast Neoplasms
1
Anal Canal Carcinoma
1
Interventions
Surveys and Questionnaires
16
Blood Specimen Collection
7
Observation
5
Surgical Procedures, Operative
4
Interviews as Topic
4
Hysteroscopy
4
Hysterectomy
4
Ultrasonography
2
Specimen Handling
2
Sentinel Lymph Node Biopsy
2
Reverse Transcriptase Polymerase Chain Reaction
2
Psychiatric Rehabilitation
2
Magnetic Resonance Spectroscopy
2
Laparoscopy
2
Immunohistochemistry
2
High-Energy Shock Waves
2
Drug Therapy
2
Data Collection
2
Biopsy
2
Base Sequence
2
trastuzumab deruxtecan
1
sarcolipin
1
rubitecan
1
olaparib
1
dostarlimab
1
apixaban
1
X-Rays
1
Vaginal Smears
1
Tissue Banks
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Endometrial Neoplasms
×
Brachytherapy
×
Clear all
NCT05242861
2022-02-16
RetroBT
Zhejiang Cancer Hospital
Recruiting
300 enrolled